{
  "@context": [
    "file://domain/_contexts/base.jsonld",
    "file://domain/_contexts/medicine.jsonld"
  ],
  "@type": [
    "EducationalResource",
    "MedicalCondition"
  ],
  "@id": "health-sciences:medicine:neurology:neuro-002",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:54:58.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "neurology-knowledge-base"
    ],
    "confidence": 0.96,
    "status": "validated",
    "modified": "2026-01-11T14:52:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/neurology",
    "type": "definition",
    "difficulty": "intermediate",
    "importance": "critical",
    "aku_id": "002",
    "keywords": [
      "hemorrhagic stroke",
      "intracerebral hemorrhage",
      "ICH",
      "hypertensive hemorrhage",
      "blood pressure management"
    ],
    "medical_specialty": "neurology",
    "clinical_context": "cerebrovascular_disease"
  },
  "content": {
    "title": "Hemorrhagic Stroke (Intracerebral Hemorrhage)",
    "summary": "Spontaneous bleeding into brain parenchyma, most commonly from hypertensive arteriopathy",
    "key_points": [
      "15-20% of all strokes; higher mortality than ischemic",
      "Hypertension is #1 cause; also CAA, AVM, anticoagulation",
      "CT head shows hyperdense (white) lesion acutely",
      "Aggressive BP reduction to SBP <140 within 1 hour (INTERACT2)",
      "Reverse anticoagulation immediately if applicable",
      "ICH Score predicts mortality"
    ],
    "statement": {
      "text": "Intracerebral hemorrhage (ICH) is spontaneous bleeding into brain parenchyma, most commonly from rupture of small penetrating arteries damaged by chronic hypertension. Management focuses on BP reduction, anticoagulation reversal, and prevention of hematoma expansion.",
      "formal": "ICH = Sudden focal deficit + CT hyperdensity in parenchyma \u2192 BP control to SBP <140 + Reverse anticoagulation + Monitor for expansion"
    },
    "explanation": {
      "intuition": "A hemorrhagic stroke is a blood vessel bursting inside the brain, spilling blood into brain tissue. Unlike ischemic stroke, the problem isn't blockage - it's leakage. The blood acts like a mass, compressing and damaging brain tissue.",
      "key_insight": "Hematoma expansion in the first hours predicts poor outcome. The two treatable factors are BP (lowering reduces expansion) and anticoagulation reversal (restores clotting ability). Quick action matters."
    },
    "definitions_glossary": {
      "intracerebral_hemorrhage": "Spontaneous bleeding into brain parenchyma (not trauma-related)",
      "hypertensive_hemorrhage": "ICH from chronic HTN-related arteriopathy; typical locations: basal ganglia, thalamus, pons, cerebellum",
      "cerebral_amyloid_angiopathy": "Amyloid deposition in cortical vessels; causes lobar hemorrhage in elderly",
      "hematoma_expansion": "Growth of hemorrhage volume in first 24 hours; predicts worse outcomes",
      "ICH_score": "Prognostic score (0-6) predicting 30-day mortality based on GCS, volume, IVH, age, infratentorial location",
      "mass_effect": "Compression of adjacent brain structures by hematoma",
      "intraventricular_hemorrhage": "IVH - blood extending into ventricles; worsens prognosis",
      "spot_sign": "Contrast extravasation on CTA predicting hematoma expansion",
      "reversal_agents": "PCC, FFP, vitamin K (for warfarin); idarucizumab (dabigatran); andexanet al.fa (Xa inhibitors)",
      "lobar_hemorrhage": "Hemorrhage in cerebral cortex; suggests CAA or vascular malformation",
      "deep_hemorrhage": "Basal ganglia, thalamus, pons hemorrhage; typically hypertensive",
      "Charcot_Bouchard_aneurysm": "Microaneurysm in small penetrating arteries from chronic hypertension"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "hypertensive_mechanism": "Chronic HTN \u2192 lipohyalinosis of small penetrating arteries \u2192 microaneurysms (Charcot-Bouchard) \u2192 rupture",
      "CAA_mechanism": "Amyloid-beta deposition in vessel walls \u2192 vessel fragility \u2192 lobar hemorrhage",
      "other_causes": [
        "Arteriovenous malformation (AVM)",
        "Coagulopathy/anticoagulation",
        "Tumor hemorrhage",
        "Vasculitis",
        "Cocaine/amphetamines"
      ]
    },
    "diagnostic_criteria": {
      "clinical": [
        "Sudden onset focal neurologic deficit",
        "Often with headache, decreased consciousness, vomiting",
        "Rapid progression over minutes to hours"
      ],
      "imaging": {
        "CT_head": "Hyperdense (white) lesion in parenchyma; acute hemorrhage immediately visible",
        "CT_angiography": "Evaluate for underlying vascular malformation; 'spot sign' predicts expansion",
        "MRI_GRE_SWI": "Microbleeds suggest CAA or chronic hypertensive disease"
      },
      "location_etiology_correlation": {
        "basal_ganglia_thalamus": "Hypertensive",
        "pons_cerebellum": "Hypertensive",
        "lobar": "CAA, AVM, tumor, coagulopathy"
      }
    },
    "ICH_score": {
      "components": [
        "GCS 3-4 = 2 pts, 5-12 = 1 pt, 13-15 = 0",
        "ICH volume \u226530mL = 1 pt",
        "IVH present = 1 pt",
        "Infratentorial origin = 1 pt",
        "Age \u226580 = 1 pt"
      ],
      "interpretation": {
        "0": "0% mortality",
        "1": "13%",
        "2": "26%",
        "3": "72%",
        "4": "97%",
        "5_6": "100%"
      }
    },
    "treatment_options": {
      "blood_pressure": {
        "target": "SBP <140 mmHg within 1 hour (INTERACT2, ATACH-2)",
        "agents": [
          "IV nicardipine",
          "IV labetalol",
          "IV clevidipine"
        ],
        "rationale": "Reduces hematoma expansion without increasing ischemia"
      },
      "anticoagulation_reversal": {
        "warfarin": "IV vitamin K 10mg + 4-factor PCC (25-50 U/kg); target INR <1.4",
        "dabigatran": "Idarucizumab 5g IV",
        "factor_Xa_inhibitors": "Andexanet al.fa (or PCC if unavailable)",
        "heparin": "Protamine sulfate"
      },
      "surgical_intervention": {
        "EVD": "For hydrocephalus from IVH",
        "craniotomy": "Consider for lobar hemorrhage with mass effect, cerebellar hemorrhage >3cm, declining consciousness",
        "minimally_invasive": "Stereotactic aspiration + thrombolysis under investigation (MISTIE-III)"
      },
      "supportive": [
        "ICP monitoring and management if indicated",
        "Glucose control",
        "Temperature management",
        "DVT prophylaxis after 24-48h if stable",
        "Seizure prophylaxis (controversial)"
      ]
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Hemorrhagic Stroke"
    },
    "altLabel": [
      {
        "@language": "en",
        "@value": "Intracerebral Hemorrhage"
      },
      {
        "@language": "en",
        "@value": "ICH"
      }
    ],
    "definition": {
      "@language": "en",
      "@value": "Spontaneous bleeding into brain parenchyma causing focal neurologic deficit and mass effect"
    },
    "notation": "neuro-002"
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "274100004",
      "uri": "http://snomed.info/id/274100004",
      "description": "Intracerebral hemorrhage (disorder)",
      "matchType": "exactMatch"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "I61",
      "description": "Nontraumatic intracerebral hemorrhage",
      "matchType": "exactMatch"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D002543",
      "uri": "http://id.nlm.nih.gov/mesh/D002543",
      "description": "Cerebral Hemorrhage",
      "matchType": "exactMatch"
    }
  ],
  "pedagogical": {
    "target_audience": [
      "neurology_residents",
      "emergency_medicine_residents",
      "neurosurgery_residents",
      "intensivists"
    ],
    "estimated_time": "40min",
    "difficulty_curve": 0.75,
    "learning_objectives": [
      "Distinguish ICH from ischemic stroke on CT",
      "Apply rapid BP reduction to SBP <140",
      "Select appropriate reversal agent for anticoagulation",
      "Calculate ICH score for prognosis",
      "Identify surgical candidates"
    ],
    "clinical_pearls": [
      "ICH has higher mortality than ischemic stroke - quick BP control is critical",
      "Spot sign on CTA = high risk of expansion - be aggressive",
      "Lobar hemorrhage in elderly without HTN = think CAA",
      "Cerebellar hemorrhage >3cm or with brainstem compression = surgical emergency",
      "4-factor PCC reverses warfarin faster than FFP"
    ],
    "board_yield": {
      "usmle_step2": "Very High",
      "neurology_boards": "Critical"
    }
  },
  "relationships": {
    "skos:related": [
      {
        "@id": "health-sciences:medicine:neurology:neuro-001",
        "@type": "skos:Concept",
        "skos:prefLabel": "Ischemic Stroke"
      },
      {
        "@id": "health-sciences:medicine:neurology:neuro-003",
        "@type": "skos:Concept",
        "skos:prefLabel": "Subarachnoid Hemorrhage"
      }
    ],
    "owl:sameAs": [
      "http://snomed.info/id/274100004",
      "http://www.wikidata.org/entity/Q189588"
    ]
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-11T14:52:00.000Z",
    "sources": [
      {
        "source": "Hemphill JC, et al. AHA/ASA ICH Guideline 2015. Stroke 2015",
        "type": "clinical_guideline",
        "year": 2015,
        "confidence": 1.0
      }
    ]
  },
  "quality_assessment": {
    "CQS": 0.94,
    "completeness": 0.95,
    "accuracy": 0.97,
    "clarity": 0.94,
    "pedagogical_quality": 0.93,
    "ontology_alignment": 0.95,
    "last_assessment": "2026-01-11T14:52:00.000Z",
    "assessor": "quality-enhancement-agent"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Intracerebral_hemorrhage",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q189588"
}